the optimal exploitation of these materials and data in terms of their‘ethically
sound’use.”^33
5 Final Observations
Let me resume my observations in the following very preliminary way: personal-
ized medicine will raise new legal questions or will, at least, shed new light on those
questions that are generally relevant for the provision of health care. At this stage of
our knowledge, it is not easy to come to clear results. We still have to understand
and to identify the legal implications of personalized medicine and its possible
meaning for the development of any legal order. This appears to be of little help.
Yet it is a first and necessary step for further research. And research is, to a
considerable extent, the art to ask the right questions.
References
Alvarado MD et al (2014) Patient preferences regarding intraoperative versus external beam
radiotherapy following breast-conserving surgery. Breast Cancer Res Treat 143:135–140.
doi:10.1007/s10549-013-2782-9
Chadwick R, Levitt M, Shickle D (2014) The right to know and the right not to know. Genetic
privacy and responsibility, 2nd edn. Cambridge University Press, Cambridge
Denford S, Frost J, Dieppe P, Cooper C, Britten N (2014) Individualisation of drug treatments for
patients with long-term conditions: a review of concepts. BMJ Open 2014:4. doi:10.1136/
bmjopen-2013-004172
Fischer T et al (2014) Individualized medicine – ethical, economical and historical perspectives.
EPMA J 5(Suppl 1):A17
Grabe HJ et al (2014) Cohort profile: Greifswald approach to individualized medicine
(GANI_MED). J Transl Med 12:144. doi:10.1186/1479-5876-12-144
Greenhalgh T, Howick J, Maskrey N (2014) Evidence based medicine: a movement in crisis? BMJ
348:g3725. doi:10.1136/bmj.g3725
Hardenberg S (2014) Genetische Gesundheitsdaten in der Individualisierten Medizin. ZD 2014
(3):115–118
Hardenberg S, Wilman N (2013) Individualisierte Medizin als Exklusiv-Medizin? MedR 31
(2):77–81
Huster S, Gottwald S (2013) Die Verg€utung genetischer Diagnostik in der Gesetzlichen
Krankenversicherung. Nomos, Baden-Baden
Juth N (2014) The right not to know and the duty to tell: the case of relatives. J Law Med Ethics 42
(1):38–52. doi:10.1111/jlme.12117
Ma Q, Lu AY (2011) Pharmacogenetics, pharmacogenomics, and individualized medicine.
Pharmacol Rev 63(2):437–459. doi:10.1124/pr.110.003533
(^33) Revermann and Sauter ( 2006 ). Available at:https://www.tab-beim-bundestag.de/en/publica
tions/reports/ab112.html.
28 U. Becker